Cephalon

SYNRIBO

Manufacturer:

Cephalon

Synribo HCPCS:

J9262

HCPCS Code Descriptor:

Injection, omacetaxine mepesuccinate, 0.01 mg

Category:

J Code

Synribo NDCs:

63459-0177-14

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Synribo:

SYNRIBO is an Oncology drug manufactured by Cephalon and administered via the Subcutaneous route of administration. The J Code: J9262 is aligned to the drug SYNRIBO.

ACCESS PRICING AND MORE BY REGISTERING

J9262 Added Date:

January 1, 2014

J9262 Effective Date:

January 1, 2014

J9262 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Synribo billing and coding information.
Synribo patient assistance information can be found through Teva Cares at the URL: http://www.tevacares.org/
SYNRIBO prescribing information can be found at the link below:
Information regarding SYNRIBO’s side effects can be found at MedlinePlus